Uterine cancer ICD 10 is not one code used for every diagnosis. The correct code depends on where the cancer began and whether it is active, previously treated, or documented without a precise location.
For example, C54.1 identifies a malignant neoplasm of the endometrium, while C55 applies when the affected part of the uterus is unspecified. These codes support medical records, insurance claims, and cancer reporting, but they do not reveal the complete stage or outlook.
What Does Uterine Cancer ICD-10 Mean?
ICD-10-CM is the diagnosis coding system used in United States healthcare settings. It converts conditions documented by healthcare professionals into standardized codes.
“Uterine cancer” is a broad term. Most cases begin in the endometrium, which is the inner lining of the uterus. Other cancers may develop in the uterine muscle or another part of the uterine body. The medical record should identify the location as clearly as possible before a code is selected.
Common ICD-10 Codes for Uterine Cancer
C54.1: Malignant Neoplasm of Endometrium
C54.1 is commonly used for confirmed endometrial cancer. Endometrial cancer begins in the uterine lining and is the most common form of uterine cancer.
C55: Malignant Neoplasm of Uterus, Part Unspecified
C55 may be used when uterine cancer is confirmed, but the medical documentation does not identify the affected part. A more specific code is preferred when pathology reports or physician notes identify the exact location.
Other Site-Specific Codes
The C54 category includes several codes based on the location of the malignancy:
- C54.0: Malignant neoplasm of isthmus uteri
- C54.1: Malignant neoplasm of endometrium
- C54.2: Malignant neoplasm of myometrium
- C54.3: Malignant neoplasm of fundus uteri
- C54.8: Malignant neoplasm of overlapping sites of corpus uteri
- C54.9: Malignant neoplasm of corpus uteri, unspecified
Cervical cancer belongs under C53, not C54 or C55. This distinction is important when reviewing a diagnosis, pathology report, or insurance statement.
How Is the Correct Code Selected?
The code should follow the clinician’s documented diagnosis rather than a symptom, scan finding, or personal assumption. Important details include the primary cancer location, confirmation status, current treatment, and whether cancer has spread.
A pathology report may identify endometrial cancer, while an operative note may describe its exact location. A qualified medical coder reviews the documentation and follows current ICD-10-CM guidelines.
Active Cancer Versus Personal History
Active uterine cancer is generally coded within C54 or C55 while the disease remains present or treatment is directed at the malignancy.
After the cancer has been removed, treatment has ended, and there is no evidence of disease at the original site, a personal-history code may be appropriate. Z85.42 means personal history of malignant neoplasm of other parts of the uterus.
Follow-up appointments, treatment complications, and secondary cancer sites can require additional codes. The full medical record determines which codes should be reported.
Does the ICD-10 Code Show the Cancer Stage?
No. An ICD-10 code identifies the condition and anatomical location, but it does not fully describe the stage, grade, cell type, molecular findings, treatment plan, or prognosis.
Two people with the C54.1 code can have very different stages. Uterine cancer staging depends on findings from pathology, surgery, imaging, lymph nodes, and whether the cancer has spread beyond the uterus.
Patients should ask their gynecologic oncologist to explain the stage instead of trying to determine it from an insurance code.
Warning Signs That Need Medical Evaluation
Abnormal vaginal bleeding is an important warning sign of endometrial cancer. This includes bleeding after menopause, spotting between periods, or menstrual bleeding that becomes unusually heavy.
Other possible symptoms include abnormal discharge, pelvic pain, discomfort during sex, and difficult or painful urination. These symptoms do not always indicate cancer, but persistent or unexplained changes should be evaluated.
Fibroids, polyps, infections, and hormonal changes can produce similar symptoms. However, bleeding after menopause should never be ignored. When abnormal bleeding or pelvic symptoms occur, an ultrasound uterine cancer evaluation can help doctors examine the uterine lining and identify changes that may require a biopsy.
Practical Safety and Risk-Reduction Tips
There is no guaranteed way to prevent uterine cancer, but maintaining a healthy weight, staying active, and managing diabetes or PCOS may lower certain risks. Discuss hormone therapy, tamoxifen, Lynch syndrome, and family history with your doctor.
Track unusual bleeding, pelvic pressure, and UTI symptoms in women, and keep copies of important medical records and test results.
When to Seek Professional Help?
Arrange a gynecology appointment for postmenopausal bleeding, repeated spotting between periods, unusually heavy bleeding, persistent pelvic pressure, or unexplained vaginal discharge.
Seek urgent medical attention for severe bleeding accompanied by dizziness, fainting, significant weakness, breathing difficulty, or sudden intense pelvic pain.
Final Thoughts
C54.1 is the uterine cancer ICD-10 code used when cancer begins in the endometrium. C55 is used when a confirmed uterine malignancy is documented without a specific uterine location.
Accurate code selection depends on the physician’s diagnosis and supporting medical records. Although a diagnosis code helps classify care, it cannot explain the full cancer stage, treatment plan, or expected outcome.
FAQs
C54.1 is used for a confirmed malignant neoplasm of the endometrium, which is the inner lining of the uterus and the most common uterine cancer site.
C55 applies when uterine cancer is confirmed, but the medical record does not identify the specific affected part of the uterus clearly enough for another code.
No. Cervical cancer is coded under C53, while cancers beginning in the uterine body generally fall within the C54 category or the unspecified C55 code.
No. It identifies the primary cancer location, but staging requires information from pathology, imaging, surgery, lymph nodes, and evidence showing whether the cancer has spread.
Z85.42 may describe a personal history of uterine malignancy after treatment when no active disease remains, depending on the documentation and applicable coding guidelines.
No. The code should come from the clinician’s documented diagnosis and be assigned by a qualified professional following official ICD-10-CM coding requirements and current guidance.
